[HTML][HTML] Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections

S Najafi, SC Tan, S Aghamiri, P Raee… - Biomedicine & …, 2022 - Elsevier
Viral infections are a common cause of morbidity worldwide. The emergence of Coronavirus
Disease 2019 (COVID-19) has led to more attention to viral infections and finding novel …

An updated review of SARS‐CoV‐2 detection methods in the context of a novel coronavirus pandemic

Y Zhang, Z Huang, J Zhu, C Li, Z Fang… - Bioengineering & …, 2023 - Wiley Online Library
Abstract The World Health Organization has reported approximately 430 million confirmed
cases of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory …

Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view

J Martin, N Tena, AG Asuero - Microchemical Journal, 2021 - Elsevier
Since December 2019, we have been in the battlefield with a new threat to the humanity
known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review …

A CRISPR/Cas12a-based fluorescence aptasensor for the rapid and sensitive detection of ampicillin

BJ Yee, NF Shafiqah, NF Mohd-Naim… - International Journal of …, 2023 - Elsevier
This study introduces CRISPR/Cas-based aptasensor for the highly sensitive and specific
detection of the antibiotic, ampicillin. Ampicillin (AMPI) is a commonly used antibiotic for …

Application of CRISPR/Cas systems in the nucleic acid detection of infectious diseases

J Li, Y Wang, B Wang, J Lou, P Ni, Y Jin, S Chen… - Diagnostics, 2022 - mdpi.com
The CRISPR/Cas system is a protective adaptive immune system against attacks from
foreign mobile genetic elements. Since the discovery of the excellent target-specific …

Newly emerged antiviral strategies for SARS-CoV-2: From deciphering viral protein structural function to the development of vaccines, antibodies, and small molecules

C Zhang, M Yang - International Journal of Molecular Sciences, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) caused by the infection of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become the most severe health crisis, causing …

COVID-19 diagnostics: Molecular biology to nanomaterials

S Perveen, A Negi, V Gopalakrishnan, S Panda… - Clinica Chimica …, 2023 - Elsevier
The SARS-CoV-2 pandemic has claimed around 6.4 million lives worldwide. The disease
symptoms range from mild flu-like infection to life-threatening complications. The …

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection

ZS Razavi, M Soltani, M Souri… - Critical Reviews in …, 2024 - Taylor & Francis
This comprehensive review delves into the advancements and challenges in biosensing,
with a strong emphasis on the transformative potential of CRISPR technology for early and …

Phytochemical Profiling and Antiviral Activity of Green Sustainable Nanoparticles Derived from Maesa indica (Roxb.) Sweet against Human Coronavirus 229E

FAM Abdelgawad, SS El-Hawary, EM Abd El-Kader… - Plants, 2023 - mdpi.com
Plant secondary metabolites are key components for new, safe and effective drugs.
Ethanolic extract of Maesa indica Roxb. Sweet (ME) aerial parts were used for biosynthesis …

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms

Z Huang, J Fang, M Zhou, Z Gong, T Xiang - Frontiers in Microbiology, 2022 - frontiersin.org
Pathogenic microorganisms have major impacts on human lives. Rapid and sensitive
diagnostic tools are urgently needed to facilitate the early treatment of microbial infections …